Please login to the form below

Not currently logged in
Email:
Password:

UK pharma

This page shows the latest UK pharma news and features for those working in and with pharma, biotech and healthcare.

UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med

UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med

The fines come following a CMA review into the conduct of several pharma companies, which found that Auden Mckenzie and Actavis UK (now known as Accord UK) charged the NHS ‘excessively ... Actavis UK also continued paying off Advanz Pharma –

Latest news

  • Nordic Capital acquires ADVANZ PHARMA for $846m Nordic Capital acquires ADVANZ PHARMA for $846m

    ADVANZ PHARMA shareholders to receive $17.26 per share under the terms of the deal. ... UK-based ADVANZ PHARMA has a strategic focus on complex medicines in Europe, with expertise in anti-infectives and endocrinology therapy areas.

  • UK government ‘concerned’ over Elliott Management’s plans for GSK UK government ‘concerned’ over Elliott Management’s plans for GSK

    The UK government has concerns over activist investor Elliott Management’s plans for GlaxoSmithKline (GSK) after the hedge fund acquired a ‘significant’ stake in the British drugmaker last month. ... Walmsley has come under increasing pressure to

  • Avenir Global moves four UK agencies into new office space in London Avenir Global moves four UK agencies into new office space in London

    Avenir Global has announced that it is moving four of its UK agencies into one office, based at Riverside House in the Bankside area of London. ... It will house four of Avenir's leading UK brands – AXON, Cherry, Hanover and Madano.

  • WebMD acquires UK-based healthcare publisher MGP WebMD acquires UK-based healthcare publisher MGP

    WebMD has acquired specialist healthcare publisher MGP, bolstering the company’s UK platform for healthcare professionals. ... Chesham, UK-based MGP produces content designed to help inform clinical decision-making and change clinical behaviour in line

  • Novartis announces delay in UK cholesterol drug study Novartis announces delay in UK cholesterol drug study

    Swiss pharma company Novartis has readjusted the timings for a major study of its cholesterol drug Leqvio in the UK, after facing issues with recruitment due to the COVID-19 pandemic. ... Initially in December as we saw, there was an uptick in COVID-19

More from news
Approximately 6 fully matching, plus 771 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    The connection with other major life sciences markets, such as the UK, is clear. ... data and patient connections, and ensuring that the UK attracts and develops the skills needed to compete globally.

  • Case study: UK Malnutrition Awareness Week 2018 Case study: UK Malnutrition Awareness Week 2018

    Client:BAPEN and the Malnutrition Task Force. Agency:M&F Health. Campaign:UK Malnutrition Awareness Week 2018. ... Timescale:N/A. One in ten people aged over 65 in the UK is malnourished or at risk of malnutrition.

  • Case study: Logic IBD Nurse Education Day and Recognition Event Case study: Logic IBD Nurse Education Day and Recognition Event

    Client:Tillotts Pharma UK Ltd. Agency:Jango Communications. Campaign:LOGIC IBD Nurse Education Day and Recognition Event. ... Timescale:N/A. Tillotts Pharma UK recognised the lack of educational and professional development opportunities available to IBD

  • The transatlantic opioid crisis The transatlantic opioid crisis

    These worrying trends, official investigations in the UK, like The Gosport Inquiry in 2018, and allegations made against British pharma business, Indivior, create fertile ground for potential litigation on these shores. ... UK pharma (and others): brace

  • The fight for affordable insulin The fight for affordable insulin

    Activists are organised, and demanding action on US insulin prices - and pointing the finger at pharma. ... Dialogue with pharma? No thanks. As with the UK’s Cystic Fibrosis Buyers’ Club advocates, T1International doesn’t see dialogue with pharma

More from intelligence
Approximately 0 fully matching, plus 58 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 86 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 38 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....